Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01397734
Title Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Beth Israel Deaconess Medical Center

chronic myeloid leukemia


Arsenic trioxide

Age Groups: adult
Covered Countries USA

No variant requirements are available.